Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets

<div>Release profiles of metformin HCl (a) and GLB (b) from three batches of the optimized monolithic fixed-dose combination orodispersible tablets.</div>

Advances in Pharmacological and Pharmaceutical Sciences

fig9

Figure 9

Figure 9: Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets 